Bioavailability of sublingual ergotamine.
作者信息
Tfelt-Hansen P, Paalzow L, Ibraheem J J
出版信息
Br J Clin Pharmacol. 1982 Feb;13(2):239-40. doi: 10.1111/j.1365-2125.1982.tb01366.x.
Abstract
摘要
相似文献
1
Bioavailability of sublingual ergotamine.舌下麦角胺的生物利用度。
Br J Clin Pharmacol. 1982 Feb;13(2):239-40. doi: 10.1111/j.1365-2125.1982.tb01366.x.
2
Plethysmographic comparison of sublingual and intramuscular ergotamine.舌下含服与肌肉注射麦角胺的体积描记法比较
Clin Pharmacol Ther. 1981 Jan;29(1):94-9. doi: 10.1038/clpt.1981.15.
3
Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.健康志愿者口服和直肠给药后麦角胺的药代动力学。
Eur J Clin Pharmacol. 1986;30(3):331-4. doi: 10.1007/BF00541538.
4
Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.连续三次给药及持续用药期间酒石酸麦角胺的全身可用性。
Eur J Clin Pharmacol. 1979 Nov;16(5):355-60. doi: 10.1007/BF00605636.
5
Myocardial infarction following administration of sublingual ergotamine.舌下含服麦角胺后发生心肌梗死。
Chest. 1982 Sep;82(3):375-6. doi: 10.1378/chest.82.3.375.
6
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.单次及重复口服剂量后，健康受试者中酒石酸麦角胺的全身可用性。
Ups J Med Sci Suppl. 1980;31:7-9.
7
Ergotamine absorption and toxicity.麦角胺的吸收与毒性。
Postgrad Med J. 1982 Jan;58(675):6-11. doi: 10.1136/pgmj.58.675.6.
8
Buccal absorption of ergotamine.麦角胺的颊部吸收
J Neurol Neurosurg Psychiatry. 1974 Oct;37(10):1116-20. doi: 10.1136/jnnp.37.10.1116.
9
Ergotamine pharmacokinetics in man: an editorial.麦角胺在人体中的药代动力学：一篇社论。
Cephalalgia. 1983 Sep;3(3):135-8. doi: 10.1046/j.1468-2982.1983.0303136.x.
10
Systemic availability of ergotamine tartrate in continuous medication.连续用药时酒石酸麦角胺的全身可用性。
Ups J Med Sci Suppl. 1980;31:20-2.
引用本文的文献
1
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.细胞色素P450 3A4抑制的药代动力学-药效学后果及临床相关性
Clin Pharmacokinet. 2000 Jan;38(1):41-57. doi: 10.2165/00003088-200038010-00003.
2
Ergotamine abuse and extra-hepatic portal hypertension.麦角胺滥用与肝外门静脉高压症
Postgrad Med J. 1985 May;61(715):461-3. doi: 10.1136/pgmj.61.715.461.
本文引用的文献
1
CLINICAL TRIAL OF INHALED ERGOTAMINE TARTRATE IN MIGRAINE.吸入性酒石酸麦角胺治疗偏头痛的临床试验
Br Med J. 1964 Jan 25;1(5377):221-4. doi: 10.1136/bmj.1.5377.221.
2
Plethysmographic comparison of sublingual and intramuscular ergotamine.舌下含服与肌肉注射麦角胺的体积描记法比较
Clin Pharmacol Ther. 1981 Jan;29(1):94-9. doi: 10.1038/clpt.1981.15.
3
The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve.单剂量酒石酸麦角胺对偏头痛患者外周动脉的影响：方法学方面及时间效应曲线
Acta Pharmacol Toxicol (Copenh). 1980 Aug;47(2):151-6. doi: 10.1111/j.1600-0773.1980.tb01855.x.
4
A new technique for recording compliance of human hand veins.一种记录人体手部静脉顺应性的新技术。
Br J Clin Pharmacol. 1981 Mar;11(3):237-43. doi: 10.1111/j.1365-2125.1981.tb00527.x.
5
Buccal absorption of ergotamine.麦角胺的颊部吸收
J Neurol Neurosurg Psychiatry. 1974 Oct;37(10):1116-20. doi: 10.1136/jnnp.37.10.1116.
Zotero 插件